Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)

This study has been completed.
Information provided by (Responsible Party):
Tesaro, Inc. Identifier:
First received: September 5, 2008
Last updated: July 23, 2013
Last verified: July 2013